Stock ALPHA PHARNEXT SCA
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pharnext SCA

Equities

ALPHA

FR001400N1P4

Pharmaceuticals

Market Closed - Euronext Paris
Other stock markets
 09:05:00 26/04/2024 pm IST 		5-day change 1st Jan Change
0.1499 EUR -8.88% Intraday chart for Pharnext SCA -12.75% -92.50%
25/04 Pharnext: share price rises on encouraging comments CF
06/03 Pharnext: listing suspended pending further update CF

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 - - - - - -
Enterprise Value (EV) 1 - - - - - -
P/E ratio - - - - - -
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA - - - - - -
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book - - - - - -
Nbr of stocks (in thousands) - - - - - -
Reference price 2 40,00,00,000 52,50,00,000 28,30,00,000 16,50,00,000 90,00,000 13,50,000
Announcement Date 24/05/18 30/04/19 30/04/20 30/04/21 29/04/22 27/04/23
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 3.321 6.829 3.597 2.81 3.565 2.258
EBITDA 1 -18.07 -17.82 -19.85 -18.17 -22.2 -27.24
EBIT 1 -18.16 -17.91 -20.03 -18.91 -22.86 -27.82
Operating Margin -546.66% -262.23% -556.66% -672.96% -641.19% -1,232.02%
Earnings before Tax (EBT) 1 -20.24 -21.32 -23.31 -21.56 -30.62 -38.45
Net income 1 -20.24 -21.32 -23.31 -21.56 -30.62 -38.45
Net margin -609.56% -312.15% -647.95% -767.27% -858.9% -1,702.72%
EPS - - - - - -
Free Cash Flow 1 -12.85 -11.28 -15.61 -10.64 -14.75 -8.646
FCF margin -386.97% -165.16% -434% -378.72% -413.76% -382.92%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 24/05/18 30/04/19 30/04/20 30/04/21 29/04/22 27/04/23
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 12.1 24.7 7.78 10.2 14.2 22.2
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -0.6685 x -1.385 x -0.3917 x -0.5589 x -0.6412 x -0.8134 x
Free Cash Flow 1 -12.9 -11.3 -15.6 -10.6 -14.7 -8.65
ROE (net income / shareholders' equity) 494% 111% 139% 218% 202% 152%
ROA (Net income/ Total Assets) -54% -44.5% -46.2% -53.2% -75.8% -143%
Assets 1 37.5 47.9 50.44 40.52 40.41 26.87
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex 1 0.16 0.39 0.07 0.02 0.08 0.04
Capex / Sales 4.83% 5.65% 2% 0.81% 2.16% 1.57%
Announcement Date 24/05/18 30/04/19 30/04/20 30/04/21 29/04/22 27/04/23
1EUR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
PHARNEXT SCA Stock Pharnext SCA
-92.50% 27.82K
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ALPHA Stock
  4. Financials Pharnext SCA